Recap: Iovance Biotherapeutics Q3 Earnings

Iovance Biotherapeutics IOVA reported its Q3 earnings results on Thursday, November 3, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Iovance Biotherapeutics beat estimated earnings by 1.56%, reporting an EPS of $-0.63 versus an estimate of $-0.64.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 2.87% drop in the share price the next day.

To track all earnings releases for Iovance Biotherapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.